Original Research
Published on 22 Aug 2023
Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations
in Multiple Sclerosis and Neuroimmunology
- 2,919 views
- 2 citations
Original Research
Published on 22 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 18 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 16 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 16 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Correction
Published on 15 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 10 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 09 Aug 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 31 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 26 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 25 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 24 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 20 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 18 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 14 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Jul 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 13 Jul 2023
in Multiple Sclerosis and Neuroimmunology